Check Closely (1)pentobarbital will minimize the level or effect of mifepristone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. CYP3A4 inducers have not been analyzed, coadministration not recommended by maker
Contraindicated (one)pentobarbital will decrease the level or influence of doravirine by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will minimize the level or impact of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Closely. Consider an increase in cannabidiol dosage (determined by scientific reaction and tolerability) when coadministered with a strong CYP3A4 inducer.
pentobarbital will lessen the extent or effect of bazedoxifene/conjugated estrogens by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will minimize the level or outcome of exemestane by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of. For people getting exemestane that has a strong CYP3A4 inducer the advised dose of exemestane is fifty mg every day after a food.
Observe Intently (2)pentobarbital will reduce the level or outcome of suvorexant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on. Robust CYP3A4 inducers may minimize suvorexant efficacy; if enhanced suvorexant dose expected, tend not to exceed 20 mg/working day
pentobarbital will lessen the level or outcome of ambrisentan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unfamiliar.
pentobarbital will lower the extent or outcome website of estradiol vaginal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
pentobarbital will minimize the level or impact of pazopanib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
pentobarbital will minimize the extent or influence of amiodarone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
pentobarbital will reduce the extent or effect of doravirine by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will reduce the level or effect of estrogens conjugated synthetic by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will decrease the level or impact of lapatinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
lasmiditan, pentobarbital. Possibly will increase effects of the other by sedation. Use Warning/Keep track of. Coadministration of lasmiditan and other CNS depressant drugs, which include alcohol have not been evaluated in medical studies. Lasmiditan may possibly trigger sedation, together with other cognitive and/or neuropsychiatric adverse reactions.